跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Miltirone
首页
药物
Miltirone
Miltirone
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Composition Comprising Tanshinone Compounds Isolated From The Extract Of Salviae Miltiorrhizae Radix For Treating Or Preventing Cognitive Dysfunction And The Use Thereof
US 2009312413 A1
申请人: DIGITAL BIOTECH CO LTD
优先权: 2005
US
Method for extracting and purifying tanshinone monomeric compounds from red sage root
CN 102167721 B
申请人: UNIV LIAOCHENG
优先权: 2011
CN
Application of miltirone to prepare medicine protecting vascular endothelial cells
CN 104095836 A
申请人: UNIV CHINA PHARMA
优先权: 2013
CN
Use of tanshinone in resisting uric acid nephropathy
CN 107913277 A
申请人: UNIV CHINA PHARMA
优先权: 2017
CN
Miltirone derivative, pharmaceutical composition thereof and application of miltirone derivative in pharmacy
CN 108047020 A
申请人: KUNMING INST BOTANY CAS
优先权: 2018
CN
Composition, preparation method and application of composition as acetylcholinesterase inhibitor
CN 110141574 A
申请人: SHANDONG ANALYSIS & TEST CT
优先权: 2019
CN
Composition containing miltirone A, miltirone and salvianolic acid H and application thereof
CN 120478329 A
申请人: SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV TCM
优先权: 2025
CN
Application of tanshinone and decitabine combined medicine in preparation of medicine for treating breast cancer
CN 122272616 A
申请人: UNIV NANTONG
优先权: 2026
CN
Astaxanthin liposome as well as preparation method and application thereof
CN 122123985 A
申请人: UNIV XIAN PEIHUA
优先权: 2026
CN
药物
反馈